Vol. 42 | No. 1 | January-June 2014 Back

Open Access

Mitral Valve Replacement: The St. Luke’s Medical Center Quezon City Experience

Sidharta Kunardi, Edgar Y. Ongjoco
Jun 2014 DOI 10.69944/pjc.ab086edc25

Abstract

INTRODUCTION: The St. Luke’s Medical Center Quezon City Heart Institute is one of the leading cardiac centers in the country. However, there has been no cardiac valve surgery census published since the establishment of the Heart Institute in 1986. 

OBJECTIVE: This study was conducted to present the institution’s experience on mitral valve surgery. 

STUDY DESIGN AND METHODOLOGY: This was a retrospective study that reviewed the cardiac valve surgery census from January 2006 to September 2013. 

RESULTS: Of the 53 patients who were admitted during the study period, 41 patients had complete medical records. The mean patient age was 44.8 years. Most patients were female (73.2%). The most common etiology of the mitral valve lesion was rheumatic heart disease. Most patients received mechanical valves (90.3%). Tricuspid valve annuloplasty was the most common concomitant procedure done (41.5%). Mortality rate was 4.9%. Hospital acquired pneumonia was the most common complication (26.8%). The mean hospital stay was 17 days.

References
  1. Galicio RP, et.al. Outcome of patients who underwent CABG with concomitant heart valve surgery at the Philippine Heart Center. PHC Journal 2007;13(2):119-123. 
  2. Rosenhek R, Iung B, Tornos P, Antunes MJ, Prendergast BD, Otto CM, et al. ESC Working Group on Valvular Heart Disease Position Paper: assessing the risk of interventions in patients with valvular heart disease. Eur Heart J. 2012 Apr;33(7):822-8, 828a, 828b. 
  3. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, et al.; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008 Sep 23;52(13):e1-142. 
  4. Bolman RM 3rd. Survival after mitral valve replacement: does the valve type and/or size make a difference? Circulation. 2007 Mar 20;115(11):1336-8. 
  5. Nowicki ER, Weintraub RW, Birkmeyer NJ, Sanders JH, Dacey LJ, Lahey SJ, at al. Mitral valve repair and replacement in northern New England. Am Heart J. 2003 Jun;145(6):1058-62.
License

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which permits use, share — copy and redistribute the material in any medium or format, adapt — remix, transform, and build upon the material, as long as you give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-sa/4.0/.